Literature DB >> 21309780

Time to rethink clinically important outcomes in platelet transfusion trials.

Nancy M Heddle1, Donald M Arnold, Kathryn E Webert.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21309780     DOI: 10.1111/j.1537-2995.2010.02982.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  4 in total

1.  Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study.

Authors:  Jason Tay; David Allan; Sara Beattie; Christopher Bredeson; Dean Fergusson; Dawn Maze; Mitchell Sabloff; Kednapa Thavorn; Alan Tinmouth
Journal:  BMJ Open       Date:  2016-10-24       Impact factor: 2.692

2.  The identification of cases of major hemorrhage during hospitalization in patients with acute leukemia using routinely recorded healthcare data.

Authors:  Aukje L Kreuger; Rutger A Middelburg; Erik A M Beckers; Karen M K de Vooght; Jaap Jan Zwaginga; Jean-Louis H Kerkhoffs; Johanna G van der Bom
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

Review 3.  Bleeding assessment and bleeding severity in thrombocytopenic patients undergoing invasive procedures.

Authors:  Frank E H P van Baarle; Emma K van de Weerdt; Bram Suurmond; Marcella C A Müller; Alexander P J Vlaar; Bart J Biemond
Journal:  Transfusion       Date:  2020-01-31       Impact factor: 3.157

4.  A study protocol for a randomised controlled trial evaluating clinical effects of platelet transfusion products: the Pathogen Reduction Evaluation and Predictive Analytical Rating Score (PREPAReS) trial.

Authors:  Paula F Ypma; Pieter F van der Meer; Nancy M Heddle; Joost A van Hilten; Theo Stijnen; Rutger A Middelburg; Tor Hervig; Johanna G van der Bom; Anneke Brand; Jean-Louis H Kerkhoffs
Journal:  BMJ Open       Date:  2016-01-27       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.